NASDAQ: ATRAAtara Biotherapeutics Inc Stock Ownership - Who owns Atara Biotherapeutics?
Insider buying vs selling
Have Atara Biotherapeutics Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Eric J. Hyllengren | EVP CFO and COO | 2025-03-03 | 1,211 | $7.00 | $8.47kSell |
| Anhco Nguyen | President and CEO | 2025-03-03 | 3,331 | $7.00 | $23.31kSell |
| Jill Henrich | EVP Chief Regulatory Officer | 2025-03-03 | 1,059 | $7.00 | $7.41kSell |
| Eric J. Hyllengren | EVP CFO and COO | 2024-11-18 | 1,364 | $11.20 | $15.27kSell |
| Anhco Nguyen | President and CEO | 2024-11-18 | 1,664 | $11.20 | $18.63kSell |
| Jill Henrich | EVP Chief Regulatory Officer | 2024-11-18 | 1,000 | $11.20 | $11.20kSell |
| Amar Murugan | EVP Chief Legal Officer | 2024-08-16 | 192 | $6.63 | $1.27kSell |
| Amar Murugan | EVP Chief Legal Officer | 2024-08-16 | 877 | $6.63 | $5.81kSell |
| Pascal Touchon | President and CEO | 2024-08-16 | 2,762 | $6.63 | $18.31kSell |
| Jill Henrich | EVP Global Head RA Quality | 2024-08-16 | 132 | $6.63 | $875.29Sell |
ATRA insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when ATRA insiders and whales buy or sell their stock.
ATRA Shareholders
What type of owners hold Atara Biotherapeutics Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Domain Partners VIII LP | 36.55% | 2,141,542 | $13.21M | Insider |
| Adiumentum Capital Fund I LP | 19.35% | 1,133,823 | $7.00M | Insider |
| Joel S. Marcus | 15.36% | 899,855 | $5.55M | Insider |
| Carol Giltner Gallagher | 11.82% | 692,264 | $4.27M | Insider |
| Isaac E. Ciechanover | 10.63% | 622,930 | $3.84M | Insider |
| Eric Dobmeier | 9.61% | 563,325 | $3.48M | Insider |
| Ecor1 Capital LLC | 9.08% | 532,134 | $3.28M | Institution |
| Redmile Group LLC | 7.54% | 441,701 | $2.73M | Institution |
| William K. Heiden | 6.13% | 359,000 | $2.22M | Insider |
| Jakob Dupont | 4.96% | 290,794 | $1.79M | Insider |
ATRA vs Biotech Stocks
Atara Biotherapeutics Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.